TGA Approval

KADCYLA trastuzumab emtansine (rch) 160 mg powder for injection vial (201622)

ARTG ID

201622

ARTG Name

KADCYLA trastuzumab emtansine (rch) 160 mg powder for injection vial

Sponsor

Roche Products Pty Ltd

ARTG Date

September 3, 2013

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ROCHE PRODUCTS PTY LTD

https://medical-cdn.nocode.com/drug_tga/a0525afc669956cba198eaf5f56f2af0.pdf

https://medical-cdn.nocode.com/drug_tga/306181507497a65ff17626fde60d38d9.pdf

Ingredient Name

Trastuzumab emtansine

Empowering clinical research with data-driven insights and AI-powered tools.

KADCYLA trastuzumab emtansine (rch) 160 mg powder for injection vial (201622) - TGA 批准文号 | MedPath